| Elsa Paulina Zacapa-reyes, LCPC | |
|
506 Avenue L, Dodge City, KS 67801-5319 | |
| (620) 227-8566 | |
| Not Available |
| Full Name | Elsa Paulina Zacapa-reyes |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 506 Avenue L, Dodge City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346614872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 2790 (Kansas) | Secondary |
| 101YP2500X | Counselor - Professional | 03076 (Kansas) | Primary |
| Entity Name | Healing Bliss Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174274674 PECOS PAC ID: 9133562333 Enrollment ID: O20240205002323 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
Valentines Party planned for the blind and the disabled on Tuesday, February 16, 2010. Event will be held at the Visually Handicapped Adults of the Valley (VHAV), 15520 Sherman Way, Van Nuys, CA 91406.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new tool to help surgeons use X-rays to track devices used in "minimally invasive" surgical procedures while also limiting the patient's exposure to radiation from the X-rays.
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elsa Paulina Zacapa-reyes, LCPC Po Box 477, Garden City, KS 67846-0477 Ph: (620) 275-0644 | Elsa Paulina Zacapa-reyes, LCPC 506 Avenue L, Dodge City, KS 67801-5319 Ph: (620) 227-8566 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
Valentines Party planned for the blind and the disabled on Tuesday, February 16, 2010. Event will be held at the Visually Handicapped Adults of the Valley (VHAV), 15520 Sherman Way, Van Nuys, CA 91406.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new tool to help surgeons use X-rays to track devices used in "minimally invasive" surgical procedures while also limiting the patient's exposure to radiation from the X-rays.
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).
› Verified 3 days ago
Brooke Cooper, LPC Counselor Medicare: Medicare Enrolled Practice Location: 506 Avenue L, Dodge City, KS 67801 Phone: 620-227-8566 Fax: 620-225-5824 | |
Mr. Timmey M Mcclure Jr., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 236 San Jose Room 125 East, Dodge City, KS 67801 Phone: 620-408-4728 | |
Vickie Diane Brass, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 11200 Lariat Way, Dodge City, KS 67801 Phone: 620-225-0276 Fax: 620-227-5219 | |
Cindy Renee Jacobs, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2101 Us Highway 50 Byp, Dodge City, KS 67801 Phone: 620-227-8566 Fax: 620-225-5824 | |
Hattie Stein, LAC, CSAT Counselor Medicare: Not Enrolled in Medicare Practice Location: 906 Central Ave, Dodge City, KS 67801 Phone: 620-339-4543 Fax: 620-227-1572 | |
Maria C Cooper, LCPC Counselor Medicare: Medicare Enrolled Practice Location: 506 Avenue L, Dodge City, KS 67801 Phone: 620-227-8566 | |
Mrs. Deanna Louise Barnett, LCPC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 100 Military Ave, Ste 116, Dodge City, KS 67801 Phone: 620-789-1428 Fax: 620-371-6465 |